Evidera
Gabriela Fernandez is a skilled professional in research and project management, currently serving as a Research Associate II at Evidera since June 2021, where responsibilities include designing patient preference research studies and overseeing project management tasks. Prior experience includes a role as a Patient Registry Research Associate at the Cystic Fibrosis Foundation, focusing on data analysis and managing Comparative Effectiveness Research (CER) committees. Gabriela's background also includes positions in administrative support and research across esteemed institutions like Boston University School of Medicine and slone Epidemiology Center, complemented by a Master of Public Health in Epidemiology & Biostatistics and a Bachelor of Science in Health Science from Boston University.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.